Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)

Share this content:
Nafamostat Efficacy and Safety in Critically Ill Patients(NICE)

Sponsors and Collaborators
Seoul National University Hospital
SK Chemicals Co.,Ltd.

Contact
Dong Ki Kim, MD, PhD.
82-2-2072-2303
dkkim73@gmail.com

Principal Investigator
Dong Ki Kim, MD, PhD, Seoul National University Hospital

ClinicalTrials.gov Identifier
NCT01486485

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters